Cite
HARVARD Citation
Dalbeth, N. et al. (n.d.). SAT0329 Lesinurad, A Novel Selective Uric Acid Reabsorption Inhibitor, in Combination with Febuxostat, in Patients with Tophaceous Gout: the Crystal Phase III Clinical Trial. Annals of the rheumatic diseases. p. 778. [Online].